Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus

Objectives Secondary antibody deficiency (SAD), associated with severe, recurrent or persistent infections, is common in patients with haematological malignancies (HM), but unifying guidance on immunoglobulin replacement therapy (IgRT) in these patients is lacking. We aimed to develop consensus stat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of haematology 2021-04, Vol.106 (4), p.439-449
Hauptverfasser:	Jolles, Stephen, Michallet, Mauricette, Agostini, Carlo, Albert, Michael H., Edgar, David, Ria, Roberto, Trentin, Livio, Lévy, Vincent
Format:	Artikel
Sprache:	eng
Schlagworte:	Agreements Dosage haematological malignancies (HM) Hematology Immunoglobulin G infections intravenous immunoglobulin (IVIg) Malignancy Patients Persistent infection secondary antibody deficiency (SAD) secondary immunodeficiency (SID) subcutaneous immunoglobulin (SCIg)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!